Variant report
Variant | nsv947913 |
---|---|
Chromosome Location | chr10:46213859-46216764 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566994211 | chr10:46213869-46213870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs564190122 | chr10:46213878-46213879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552685901 | chr10:46213889-46213890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577752605 | chr10:46213891-46213892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs397833219 | chr10:46213908-46213909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4042570 | chr10:46213921-46213922 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191182492 | chr10:46213970-46213971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575507544 | chr10:46214003-46214004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs17159087 | chr10:46214016-46214017 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs149366758 | chr10:46214037-46214038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574115495 | chr10:46214038-46214039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541524792 | chr10:46214049-46214050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs397839792 | chr10:46214052-46214053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559842308 | chr10:46214082-46214083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533316568 | chr10:46214187-46214188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs397833405 | chr10:46214202-46214203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551960955 | chr10:46214256-46214257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183099067 | chr10:46214257-46214258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188427955 | chr10:46214274-46214275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549295700 | chr10:46214302-46214303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs397833404 | chr10:46214313-46214314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191758009 | chr10:46214314-46214315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534356803 | chr10:46214349-46214350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs17835688 | chr10:46214364-46214365 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs183526259 | chr10:46214372-46214373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538417698 | chr10:46214420-46214421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs557137446 | chr10:46214423-46214424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575423588 | chr10:46214430-46214431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146334285 | chr10:46214438-46214439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs61265897 | chr10:46214439-46214440 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs531347219 | chr10:46214451-46214452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551865650 | chr10:46214464-46214465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs397834747 | chr10:46214471-46214472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs187868719 | chr10:46214504-46214505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541438441 | chr10:46214506-46214507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs559546702 | chr10:46214514-46214515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191612776 | chr10:46214526-46214527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183787203 | chr10:46214563-46214564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs563883836 | chr10:46214574-46214575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144210692 | chr10:46214622-46214623 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
41 | rs77821754 | chr10:46214642-46214643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561293234 | chr10:46214648-46214649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528032078 | chr10:46214653-46214654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546587900 | chr10:46214656-46214657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571222975 | chr10:46214660-46214661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532257988 | chr10:46214725-46214726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550435030 | chr10:46214730-46214731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11239594 | chr10:46214731-46214732 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
49 | rs113623171 | chr10:46214735-46214736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs3964807 | chr10:46214751-46214752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Obesity | 21956041 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21785460 | CNVD |
Developmental delay | 21948486 | CNVD |
Dysmorphic features | 21948486 | CNVD |
Epilepsy | 21948486 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Autism | 19287141 | CNVD |
Intellectual disability | 21948486 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 17431168 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Schizophrenia | 23813976 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Breast cancer | 20409316 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Rett syndrome | 21593744 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Intellectual disability | 22045946 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Schizophrenia | 20967226 | CNVD |
Cognitive impairment | 21505072 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:46199800-46221600 | Weak transcription | Primary T cells from cord blood | blood |
2 | chr10:46201400-46221000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr10:46206400-46221000 | Weak transcription | Liver | Liver |
4 | chr10:46206400-46221600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr10:46212400-46214000 | Enhancers | HepG2 | liver |
6 | chr10:46213000-46221000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |